control and SOP compliance

Process validation and cleaning validation

Equipment qualification and calibration

Stability study protocols and data trending

Personnel training and hygiene

Handling of deviations, CAPAs, and complaints

Packaging, labeling, and batch traceability

Deficiency Classification in SAHPRA Reports

• SAHPRA classifies audit observations into:
  • Critical: Direct threat to patient safety or product quality
  • Major: Significant GMP non-conformities with potential quality impact
  • Minor: Non-compliances with limited regulatory impact
• Facilities receiving:
  • One or more Critical or multiple Major deficiencies may be classified as “Non-Compliant”
  • Compliant facilities receive a GMP certificate valid for up to 3 years

Post-Inspection Compliance Expectations

1. Inspection Report: SAHPRA issues a detailed report summarizing observations and classification
2. CAPA Submission: Manufacturers must respond within 30 days with:
   • Root cause analysis
   • Corrective and preventive actions
   • Implementation timelines
   • Designated personnel and effectiveness review plan
3. Re-Inspection: May be required for Critical or unresolved Major deficiencies
4. GMP Certificate: Issued only after satisfactory CAPA closure and quality system evaluation

Key Focus Areas in Recent SAHPRA Inspections

• Inadequate electronic data security and audit trail controls
• Failure to validate cleaning processes for multi-product equipment
• Gaps in environmental monitoring for aseptic areas
• Deviation handling without trend analysis
• Training deficiencies for contract manufacturing staff

Licensing and GMP Certification in South Africa

• Manufacturing and import licenses are only granted after successful GMP audit and compliance approval
• GMP Certificates issued by SAHPRA are accepted by many African regional regulators
• Facilities intending to supply donor-funded programs must meet additional WHO PQP or Global Fund criteria

Digitalization Trends in SAHPRA GMP Oversight

• Increased adoption of electronic documentation and e-BMRs
• Integration of computerized systems (LIMS, QMS platforms) into audit scope
• Future plans for remote audits and hybrid inspections
• Emphasis on cybersecurity, data access control, and backup protocols

Inspection Preparation Checklist for SAHPRA

1. Update and validate the Site Master File
2. Ensure all quality-critical SOPs are signed, implemented, and archived
3. Compile CAPA trackers, deviation logs, change controls, and validation summaries
4. Ensure training records and job descriptions are current and role-specific
5. Simulate an internal audit based on past SAHPRA observations and global GMP trends

SAHPRA’s Role in Global GMP Convergence

• Member of:
  • PIC/S (Pharmaceutical Inspection Co-operation Scheme)
  • WHO Regulatory Collaboration and Prequalification Programmes
  • Continental efforts through African Medicines Agency (AMA)
• SAHPRA inspection reports are used for reliance and collaborative regulatory decision-making

Conclusion

SAHPRA’s GMP inspection protocol reflects its commitment to regulatory excellence and alignment with global standards. For pharmaceutical manufacturers operating in or exporting to South Africa, understanding SAHPRA’s expectations is vital for maintaining compliance, securing market access, and building international credibility. Through structured audits, risk classification, and CAPA verification, SAHPRA ensures that medicines distributed in South Africa meet the highest standards of quality and safety.